AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Feb 18, 2015
30016_dirs_2015-02-18_b77574d7-0f60-49e8-8641-6e2dbfdbda45.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-14
Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-14 | Common Stock | M | 887 | — | Acquired | 432017 | Direct |
| 2015-02-14 | Common Stock | M | 1080 | — | Acquired | 433097 | Direct |
| 2015-02-14 | Common Stock | M | 1200 | — | Acquired | 434297 | Direct |
| 2015-02-14 | Common Stock | M | 1200 | — | Acquired | 435497 | Direct |
| 2015-02-14 | Common Stock | M | 1600 | — | Acquired | 437097 | Direct |
| 2015-02-14 | Common Stock | F | 2974 | $159.08 | Disposed | 434123 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-14 | Non-Qualified Stock Option (right to buy) | $159.08 | A | 74316 | Acquired | 2025-02-13 | Common Stock (74316) | Direct |
| 2015-02-14 | Incentive Stock Option (right to buy) | $159.08 | A | 628 | Acquired | 2025-02-13 | Common Stock (628) | Direct |
| 2015-02-14 | Restricted Stock Unit | $ | M | 887 | Disposed | Common Stock (887) | Direct | |
| 2015-02-14 | Restricted Stock Unit | $ | M | 1080 | Disposed | Common Stock (1080) | Direct | |
| 2015-02-14 | Restricted Stock Unit | $ | M | 1200 | Disposed | Common Stock (1200) | Direct | |
| 2015-02-14 | Restricted Stock Unit | $ | M | 1200 | Disposed | Common Stock (1200) | Direct | |
| 2015-02-14 | Restricted Stock Unit | $ | M | 1600 | Disposed | Common Stock (1600) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49000 | Indirect |
Footnotes
F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that becomes exercisable as to 14,989 shares on 02/14/2016, 02/14/2017, 02/14/2018 and 02/14/2019, and the remaining 14,360 shares on 02/14/2020.
F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests on the fifth anniversary date (02/14/2020) of the grant.
F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.
F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.
F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.